GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,518 | -40.0% | 4,379 | 0.0% | 0.00% | – |
Q4 2022 | $9,196 | -82.3% | 4,379 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $52,000 | +44.4% | 4,379 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $36,000 | -5.3% | 4,379 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $38,000 | -24.0% | 4,379 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $50,000 | -9.1% | 4,379 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $55,000 | +52.8% | 4,379 | 0.0% | 0.00% | +100.0% |
Q2 2021 | $36,000 | -12.2% | 4,379 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $41,000 | -2.4% | 4,379 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $42,000 | -22.2% | 4,379 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $54,000 | -5.3% | 4,379 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $57,000 | +58.3% | 4,379 | +22.8% | 0.00% | +50.0% |
Q1 2020 | $36,000 | -35.7% | 3,566 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $56,000 | -6.7% | 3,566 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $60,000 | +57.9% | 3,566 | +106.4% | 0.00% | +50.0% |
Q2 2019 | $38,000 | +90.0% | 1,728 | +88.9% | 0.00% | +100.0% |
Q1 2019 | $20,000 | – | 915 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |